183sek
-1,1 %
Date:2024-10-22Time:17:29:00Latest report:Q2-2024List:First NorthTicker:SPEC
Market Cap:178 msekEnterprise Value:148 msekNet Sales:- msekEarnings:-21,2 msekEmployees:0ISIN:SE0007158118

Ratios

10-year key figure history for SpectraCure turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for SpectraCure with index and moving average MA50 and MA200.

Stockprice:1,83
MA50:2,23
MA200:2,60
Price/MA200:-29,8 %
RSI (14):32,4
Price/MA50:-18,2 %

Description

SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.

Medical Equipment